The Evolving Therapeutic Approaches for Epstein-Barr Virus Infection in Immunocompetent and Immunocompromised Individuals

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|3|2|137-142

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.3, Iss.2, 2003-06, pp. : 137-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A ReviewCytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A Review

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 179-187

Bentham Science Publishers

Access to resources Recommend Favorite

Immunosuppressants: Epstein-Barr virus infection in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Lytic replication of Epstein–Barr virus

By Lu Chih-Chung   Chen Mei-Ru  

Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. : 435-446

Future Medicine

Access to resources Recommend Favorite

Romidepsin: First reports of Epstein-Barr virus infection and hepatitis B reactivation: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1291, 2010-01 ,pp. : 40-41

Adis International

Access to resources Recommend Favorite

Epstein–Barr virus and autoimmunity: the role of a latent viral infection in multiple sclerosis and systemic lupus erythematosus pathogenesis

By Casiraghi Costanza   Horwitz Marc S  

Future Virology, Vol. 8, Iss. 2, 2013-02 ,pp. : 173-182

Future Medicine

Access to resources Recommend Favorite